ELV Q3 2021 Earnings — Elevance Health Inc. Revenue & Financial Results | Market Cap Arena

ELVElevance Health Inc.

$64B

Q3 2021 Earnings

Healthcare Medical - Healthcare Plans

Income Statement

Revenue

$35.8B+15.0% YoY

Gross Profit

$9.2B25.6% margin

Operating Income

$2.2B6.1% margin

Net Income

$1.5B4.2% margin

EPS (Diluted)

$6.13

QoQ Revenue Growth

+5.8%

Cash Flow

Operating Cash Flow

$2.5B

Free Cash Flow

$2.2B

Stock-Based Comp.

$63M

Balance Sheet

Total Assets

$98.1B

Total Liabilities

$62.3B

Stockholders' Equity

$35.7B

Cash & Equivalents

$5.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35.8B	$31.2B	+15.0%
Gross Profit	$9.2B	$8.2B	+11.4%
Operating Income	$2.2B	$617M	+256.1%
Net Income	$1.5B	$222M	+579.7%

Revenue Segments

Government Business Segment

$21.7B53%

Commercial Specialty Business Segment

$9.9B24%

IngenioRx Segment

$6.5B16%

Other Segment

$2.7B7%